INT-210 Capsule for colitis, ulcerative

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Jun 2026: Trial started, NCT07692165
  2. 9 Jul 2026: Trial registered, NCT07692165

The trials

NCT07692165: A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis

State
Under way
Phase
Phase 1 and Phase 2
People
24 planned
Started
11 Jun 2026
Primary completion
Jun 2028
Arms
200 mg INT-210 capsule, 400 mg INT-210 capsule
Results
None posted
  1. 11 Jun 2026: Trial started
  2. 9 Jul 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.